Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult Hydrocephalus (Multimod'HCA)

November 30, 2023 updated by: University Hospital, Tours

Idiopathic chronic adult hydrocephalus (ICAH) is due to expansion of the fluid-filled cavities in the brain. The clinical symptoms are gait disturbance, mental decline and incontinence. Treatment involves installing a ventriculoperitoneal shunt which is known to be able to induce regression of the symptoms in many cases meaning that ICAH is a classic, curable cause of dementia. Diagnosis relies on comparing symptoms before and after depleting cerebrospinal fluid (CSF) via a lumbar puncture (LP). In practice, the situation is complicated: improvement is often incomplete and there is no consensus on either how to assess the symptoms or how they change after CSF depletion. In consequence, the decision whether not to undertake surgery often depends on the neurosurgeon's clinical impression.

Over recent years, the cognitive profile of patients with ICAH has become better characterised and reproducible, objective techniques have been developed to assess motor function and CSF flow in the brain.

The investigators project aims to define the value of these new investigative techniques in the positive diagnosis of ICAH, in comparison to current decision-making tools.

Study Overview

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tours, France, 37044
        • CHRU de Tours

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult 65 years or older
  • Hospitalized patients (at the University Hospital of Tours) requiring the assessment of chronic hydrocephalus in adults, suspected clinically
  • Patient undergoing Lumbar Puncture subtractive
  • Informed consent form signed
  • Affiliated to a medical insurance

Exclusion Criteria:

  • Contraindications to MRI
  • Inability to walk or to stand before having lumbar puncture
  • Patient under trusteeship and guardianship, or judicial protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diagnosis of ICAH

One arm: patients with chronic adult hydrocephalus.

All patients have: Computerised gait analysis, Ultrasound measurement of cerebral pulsatility, MRI flow, Urinary incontinence scale

Diagnosis of ICAH using new investigative techniques (computerised gait analysis, ultrasound, MRI flow, urinary incontinence scale)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cerebrospinal fluid biomarkers of degeneration from Alzheimer's disease.
Time Frame: 5 days
Association between the decision-making with regard to permanent CSF shunt and the response to subtractive lumbar puncture
5 days
Computerised gait analysis
Time Frame: 5 days
Association between the decision-making with regard to permanent CSF shunt and the Computerised gait analysis,
5 days
Ultrasound measurement of cerebral pulsatility
Time Frame: 5 days
Association between the decision-making with regard to permanent CSF shunt and the Ultrasound measurement of cerebral pulsatility,
5 days
Qualitative and quantitative analysis (average speed and flow) of the hydrodynamic characteristics of the cerebrospinal fluid.
Time Frame: 5 days
Association between the decision-making with regard to permanent CSF shunt and the MRI flow,
5 days
Urinary incontinence
Time Frame: 5 days
Association between the decision-making with regard to permanent CSF shunt and the Urinary incontinence scale
5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karl MONDON, CHRU de Tours

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 21, 2014

Primary Completion (Actual)

July 21, 2018

Study Completion (Actual)

July 21, 2018

Study Registration Dates

First Submitted

July 18, 2014

First Submitted That Met QC Criteria

October 27, 2014

First Posted (Estimated)

October 30, 2014

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

January 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Adult Hydrocephalus

3
Subscribe